Access to this website is intended for the use of Healthcare Professionals only. By clicking the button "I agree" herebelow, you certify being a Healthcare Professional.

Slide narration fév 24, 2015

How do we further reduce angina in patients already treated with a hemodynamic agent?

Click to enlarge the figure  Click to enlarge the figure  Click to enlarge the figure  NB: The graph only illustrates results on number of angina attacks weekly. Click to enlarge Read more…

Weekly article fév 17, 2015

Are women at higher risk of death after MI ?

While some studies suggest that women are at higher risk of death after ST-segment elevation myocardial infarction (STEMI), other studies have found no gender-based differences in mortality. These conflicting data Read more…

Weekly article fév 10, 2015

What is the 5-year mortality for STE-ACS and NSTE-ACS?

Data on the long-term outcomes of acute coronary syndromes (ACS) generally come from large clinical trials. As a result, they do not always reflect the real-life setting insofar as these Read more…

Weekly article fév 4, 2015

In non-obese patients, sleep apnea is associated with early atherosclerosis

Sleep apnea and obesity often coexist and each of these factors is strongly associated with the development of cardiovascular disease, particularly coronary artery disease. Furthermore, obesity is an independent risk Read more…

Slide narration jan 28, 2015

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials

Click to enlarge the figure  Click to enlarge the figure  Click to enlarge the figure  Click to enlarge the figure  Click to enlarge the figure  Click to enlarge the figure 

Weekly article jan 20, 2015

Select antihypertensives according to body mass index?

Hypertension is the most widespread modifiable cardiovascular risk factor in the world with a particularly high prevalence in obese subjects. Up until now, experts have not established any specific guidelines Read more…

Weekly article jan 13, 2015

High-dose statins to prevent renal failure after coronary angiography

Impaired renal function secondary to injection of a contrast agent constitutes a real clinical practice problem because it is often accompanied by a longer duration and higher cost of hospitalisation Read more…

Weekly article déc 16, 2014

Preventing cardiovascular disease with influenza vaccine

There is a large body of evidence demonstrating that influenza vaccination has a protective effect against cardiovascular disease, even outside the epidemic period which suggests that prevention of infection is Read more…

Can we prevent myocardial and renal revascularization injury?

Click to enlarge the figure  The incidence of contrast-induced nephropathy (CIN) is highly dependent on the renal function before contrast media administration and additional risk factors, of which diabetes mellitus Read more…

Slide narration déc 9, 2014

Can we prevent myocardial and renal revascularization injury?

Click to enlarge the figure  The incidence of contrast-induced nephropathy (CIN) is highly dependent on the renal function before contrast media administration and additional risk factors, of which diabetes mellitus Read more…

Pages :1234567...27»

To have access to the
Cardiotimes Premium service,
please click here